Zobrazeno 1 - 10
of 165
pro vyhledávání: '"Roy-Luzarraga M"'
Autor:
Roy-Luzarraga M; Barts Cancer Institute-A CR-UK Center of Excellence, Queen Mary University of London, John Vane Science Center, Charterhouse Square, London, United Kingdom., Reynolds LE; Barts Cancer Institute-A CR-UK Center of Excellence, Queen Mary University of London, John Vane Science Center, Charterhouse Square, London, United Kingdom., de Luxán-Delgado B; Barts Cancer Institute-A CR-UK Center of Excellence, Queen Mary University of London, John Vane Science Center, Charterhouse Square, London, United Kingdom., Maiques O; Barts Cancer Institute-A CR-UK Center of Excellence, Queen Mary University of London, John Vane Science Center, Charterhouse Square, London, United Kingdom., Wisniewski L; Barts Cancer Institute-A CR-UK Center of Excellence, Queen Mary University of London, John Vane Science Center, Charterhouse Square, London, United Kingdom., Newport E; Barts Cancer Institute-A CR-UK Center of Excellence, Queen Mary University of London, John Vane Science Center, Charterhouse Square, London, United Kingdom., Rajeeve V; Barts Cancer Institute-A CR-UK Center of Excellence, Queen Mary University of London, John Vane Science Center, Charterhouse Square, London, United Kingdom., Drake RJG; Barts Cancer Institute-A CR-UK Center of Excellence, Queen Mary University of London, John Vane Science Center, Charterhouse Square, London, United Kingdom., Gómez-Escudero J; Barts Cancer Institute-A CR-UK Center of Excellence, Queen Mary University of London, John Vane Science Center, Charterhouse Square, London, United Kingdom., Richards FM; Translational Medicine Operations, Astrazeneca Oncology, Darwin Building, Cambridge Science Park, Milton Road, Cambridge, United Kingdom., Weller C; Department of Dermatology, Section of Clinical and Molecular Dermatology, Venereology and Allergology, University Medical Center and European Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Dormann C; Department of Dermatology, Section of Clinical and Molecular Dermatology, Venereology and Allergology, University Medical Center and European Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Meng YM; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China., Vermeulen PB; Department of Oncological Research, Translational Cancer Research Unit, Oncology Center GZA-GZA Hospitals St. Augustinus and University of Antwerp, Antwerp, Belgium., Saur D; Division of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg and Chair of Translational Cancer Research and Institute for Experimental Cancer Therapy, Klinikum rechts der Isar, School of Medicine, Technische Universität München, München, Germany., Sanz-Moreno V; Barts Cancer Institute-A CR-UK Center of Excellence, Queen Mary University of London, John Vane Science Center, Charterhouse Square, London, United Kingdom., Wong PP; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China., Géraud C; Department of Dermatology, Section of Clinical and Molecular Dermatology, Venereology and Allergology, University Medical Center and European Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Cutillas PR; Barts Cancer Institute-A CR-UK Center of Excellence, Queen Mary University of London, John Vane Science Center, Charterhouse Square, London, United Kingdom., Hodivala-Dilke K; Barts Cancer Institute-A CR-UK Center of Excellence, Queen Mary University of London, John Vane Science Center, Charterhouse Square, London, United Kingdom.
Publikováno v:
Cancer research [Cancer Res] 2022 May 16; Vol. 82 (10), pp. 1909-1925.
Autor:
Lees DM; Adhesion and Angiogenesis Laboratory, Centre for Tumour Microenvironment, Barts Cancer Institute - a CR-UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Reynolds LE; Adhesion and Angiogenesis Laboratory, Centre for Tumour Microenvironment, Barts Cancer Institute - a CR-UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Pedrosa AR; Adhesion and Angiogenesis Laboratory, Centre for Tumour Microenvironment, Barts Cancer Institute - a CR-UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Roy-Luzarraga M; Adhesion and Angiogenesis Laboratory, Centre for Tumour Microenvironment, Barts Cancer Institute - a CR-UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Hodivala-Dilke KM; Adhesion and Angiogenesis Laboratory, Centre for Tumour Microenvironment, Barts Cancer Institute - a CR-UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK. k.hodivala-dilke@qmul.ac.uk.
Publikováno v:
Angiogenesis [Angiogenesis] 2021 Aug; Vol. 24 (3), pp. 483-487.
Autor:
Lees DM; Adhesion and Angiogenesis Laboratory, Centre for Tumour Microenvironment, Barts Cancer Institute - a CR-UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Reynolds LE; Adhesion and Angiogenesis Laboratory, Centre for Tumour Microenvironment, Barts Cancer Institute - a CR-UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Pedrosa AR; Adhesion and Angiogenesis Laboratory, Centre for Tumour Microenvironment, Barts Cancer Institute - a CR-UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Roy-Luzarraga M; Adhesion and Angiogenesis Laboratory, Centre for Tumour Microenvironment, Barts Cancer Institute - a CR-UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Hodivala-Dilke KM; Adhesion and Angiogenesis Laboratory, Centre for Tumour Microenvironment, Barts Cancer Institute - a CR-UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK. k.hodivala-dilke@qmul.ac.uk.
Publikováno v:
Angiogenesis [Angiogenesis] 2021 Aug; Vol. 24 (3), pp. 471-482. Date of Electronic Publication: 2021 Mar 17.
Autor:
Günther, Andrzej1 (AUTHOR) andrzej.gunther@me.pl, Zalewski, Przemysław2,3 (AUTHOR) pzalewski@ump.edu.pl, Sip, Szymon2 (AUTHOR) szymonsip@ump.edu.pl, Bednarczyk-Cwynar, Barbara1,4 (AUTHOR)
Publikováno v:
Molecules. Aug2024, Vol. 29 Issue 15, p3623. 23p.
Autor:
Delvecchio FR; Centre for Tumor Biology, Barts Cancer Institute, Cancer Research UK Barts Centre, Queen Mary University of London, London, United Kingdom; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Fincham REA; Centre for Tumor Biology, Barts Cancer Institute, Cancer Research UK Barts Centre, Queen Mary University of London, London, United Kingdom., Spear S; Centre for Tumor Micro-environment, Barts Cancer Institute, Cancer Research UK Barts Centre, Queen Mary University of London, London, United Kingdom., Clear A; Centre for Haemato-Oncology, Barts Cancer Institute, Cancer Research UK Barts Centre, Queen Mary University of London, London, United Kingdom., Roy-Luzarraga M; Centre for Tumor Biology, Barts Cancer Institute, Cancer Research UK Barts Centre, Queen Mary University of London, London, United Kingdom., Balkwill FR; Centre for Tumor Micro-environment, Barts Cancer Institute, Cancer Research UK Barts Centre, Queen Mary University of London, London, United Kingdom., Gribben JG; Centre for Haemato-Oncology, Barts Cancer Institute, Cancer Research UK Barts Centre, Queen Mary University of London, London, United Kingdom., Bombardieri M; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Hodivala-Dilke K; Centre for Tumor Biology, Barts Cancer Institute, Cancer Research UK Barts Centre, Queen Mary University of London, London, United Kingdom., Capasso M; Centre for Tumor Micro-environment, Barts Cancer Institute, Cancer Research UK Barts Centre, Queen Mary University of London, London, United Kingdom; German Centre for Neurodegenerative Diseases, Bonn, Germany., Kocher HM; Centre for Tumor Biology, Barts Cancer Institute, Cancer Research UK Barts Centre, Queen Mary University of London, London, United Kingdom. Electronic address: h.kocher@qmul.ac.uk.
Publikováno v:
Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2021; Vol. 12 (5), pp. 1543-1565. Date of Electronic Publication: 2021 Jul 09.
Autor:
Roy-Luzarraga M; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, United Kingdom., Abdel-Fatah T; Department of Clinical Oncology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.; Pathology Department, National Liver Institute, Minoufyia University, Al Minufiyah, Egypt., Reynolds LE; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, United Kingdom., Clear A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, United Kingdom., Taylor JG; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, United Kingdom., Gribben JG; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, United Kingdom., Chan S; Department of Clinical Oncology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Jones L; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, United Kingdom., Hodivala-Dilke K; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, United Kingdom.
Publikováno v:
JAMA network open [JAMA Netw Open] 2020 Oct 01; Vol. 3 (10), pp. e2019304. Date of Electronic Publication: 2020 Oct 01.
Autor:
Demircioglu F; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Wang J; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Candido J; Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Costa ASH; MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK., Casado P; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., de Luxan Delgado B; Centre for Stem Cells in Cancer and Ageing, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Reynolds LE; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Gomez-Escudero J; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Newport E; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Rajeeve V; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Baker AM; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Roy-Luzarraga M; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Graham TA; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Foster J; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Wang Y; ChemoCentryx Inc., 850 Maude Ave, Mountain View, CA94043, USA., Campbell JJ; ChemoCentryx Inc., 850 Maude Ave, Mountain View, CA94043, USA., Singh R; ChemoCentryx Inc., 850 Maude Ave, Mountain View, CA94043, USA., Zhang P; ChemoCentryx Inc., 850 Maude Ave, Mountain View, CA94043, USA., Schall TJ; ChemoCentryx Inc., 850 Maude Ave, Mountain View, CA94043, USA., Balkwill FR; Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Sosabowski J; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Cutillas PR; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK., Frezza C; MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK., Sancho P; Centre for Stem Cells in Cancer and Ageing, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.; IIS Aragon, Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain., Hodivala-Dilke K; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK. K.Hodivala-Dilke@qmul.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2020 Mar 10; Vol. 11 (1), pp. 1290. Date of Electronic Publication: 2020 Mar 10.
Autor:
Guelfi S; Department of Oncology, VIB-KU Leuven Center for Cancer Biology and KU Leuven, Leuven, Belgium., Hodivala-Dilke K; Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, UK. k.hodivala-dilke@qmul.ac.uk., Bergers G; Department of Oncology, VIB-KU Leuven Center for Cancer Biology and KU Leuven, Leuven, Belgium. gabriele.bergers@kuleuven.be.
Publikováno v:
Nature reviews. Cancer [Nat Rev Cancer] 2024 Oct; Vol. 24 (10), pp. 655-675. Date of Electronic Publication: 2024 Aug 29.
Autor:
Zhang, Yuyuan1 (AUTHOR), Xu, Mengjun2 (AUTHOR), Ren, Yuqing3 (AUTHOR), Ba, Yuhao1 (AUTHOR), Liu, Shutong1 (AUTHOR), Zuo, Anning1 (AUTHOR), Xu, Hui1 (AUTHOR), Weng, Siyuan1 (AUTHOR), Han, Xinwei1,4,5 (AUTHOR) fcchanxw@zzu.edu.cn, Liu, Zaoqu1,4,5,6 (AUTHOR) liuzaoqu@163.com
Publikováno v:
Molecular Cancer. 4/6/2024, Vol. 23 Issue 1, p1-20. 20p.
Autor:
Chen, Peng-Cheng1 (AUTHOR), Ning, Yong1 (AUTHOR), Li, Hui2 (AUTHOR), Su, Jin-Gen1 (AUTHOR), Shen, Jiang-Bo1 (AUTHOR), Feng, Qing-Chun1 (AUTHOR), Jiang, Shu-Heng2 (AUTHOR), Shi, Pei-Dong1 (AUTHOR) shipeidong9410@163.com, Guo, Run-Sheng1 (AUTHOR) grs982600@163.com
Publikováno v:
Cellular Oncology (2211-3428). Feb2024, Vol. 47 Issue 1, p81-96. 16p.